Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, Gutzmer R, Utikal JS, Goldinger SM, Geier M, Hassel JC, Balermpas P, Kiecker F, Rauschenberg R, Dietrich U, Clemens P, Berking C, Grabenbauer G, Schadendorf D, Grabbe S, Schuler G, Fietkau R, Distel L, Heinzerling L (2018)
Publication Type: Journal article
Publication year: 2018
Book Volume: 118
Pages Range: 785-792
Journal Issue: 6
DOI: 10.1038/bjc.2017.489
This corrects the article DOI: 10.1038/bjc.2017.85.
APA:
Hecht, M., Meier, F., Zimmer, L., Polat, B., Loquai, C., Weishaupt, C.,... Heinzerling, L. (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British Journal of Cancer, 118(6), 785-792. https://doi.org/10.1038/bjc.2017.489
MLA:
Hecht, Markus, et al. "Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients." British Journal of Cancer 118.6 (2018): 785-792.
BibTeX: Download